Stock Events

Stock Events

Braxia Scientific 

€0.002000
28
-€0.00-0% Tuesday 20:00

Statistics

Day High
-
Day Low
-
52W High
0.002
52W Low
0.002
Volume
-
Avg. Volume
0
Mkt Cap
527,416
P/E Ratio
-
Dividend Yield
-
Dividend
-

Financials

-684.2%Profit Margin
Unprofitable
2019
2020
2021
2022
1.34MRevenue
-9.16MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 4960.STU. It's not an investment recommendation.
Apple
5
AAPL
Microsoft
5
MSFT
AT&T
5
T
Tesla
4
TSLA

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Compass Pathways
CMPS
Mkt Cap1.84B
Compass Pathways operates in the psychedelic medicine space, focusing on psilocybin therapy for depression, directly competing with Braxia's ketamine treatments for similar mental health conditions.
GH Research
GHRS
Mkt Cap1.82B
GH Research is involved in the development of therapeutics based on psychedelic substances for mental health disorders, competing in the same emerging sector as Braxia.
AtaiBeckley
ATAI
Mkt Cap1.9B
ATAI Life Sciences is a biotech company with a focus on psychedelic and digital therapeutics for mental health, making it a direct competitor in the psychedelic treatment market.
Nuveen Municipal Income
NUMI
Mkt Cap0
Numinus Wellness focuses on psychedelic production and therapy, including mental health treatments, positioning it as a competitor in the same niche as Braxia.
Revive Therapeutics
RVVTF
Mkt Cap9.15M
Revive Therapeutics explores the use of psychedelics in treatments for various disorders, including mental health, which competes with Braxia's focus areas.

About

Braxia Scientific Corp. functions as a medical research entity that also runs clinics, offering ketamine therapies to individuals suffering from depression and linked conditions. Beyond its clinical services, the company is actively engaged in discovering and bringing to market novel pharmaceutical compounds and innovative delivery methods. Leveraging its intellectual property development platform, Braxia Scientific innovates by developing derivatives of ketamine and psilocybin, in addition to other psychedelic substances. The organization further owns and operates several multidisciplinary clinics focused on treating a broad spectrum of mental health disorders. Braxia Scientific Corp.'s main office is located in Mississauga, Ontario.
Show more...
CEO
ISIN
CA1057361026

Listings

STU
DE
4960.STU
MU
DE
4960.MU
CN
CA
SHRM.CN
OTC Link
US
BRAXF

0 Comments

Share your thoughts

FAQ

What is Braxia Scientific stock price today?▼
The current price of 4960.STU is €0.00 EUR — it has decreased by -0% in the past 24 hours. Watch Braxia Scientific stock price performance more closely on the chart.
What is Braxia Scientific stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange Braxia Scientific stocks are traded under the ticker 4960.STU.
Is Braxia Scientific stock price growing?▼
4960.STU stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Braxia Scientific has showed a +0% increase.
What is Braxia Scientific market cap?▼
Today Braxia Scientific has the market capitalization of 527,416
What is Braxia Scientific revenue for the last year?▼
Braxia Scientific revenue for the last year amounts to 1.34M EUR.
What is Braxia Scientific net income for the last year?▼
4960.STU net income for the last year is -9.16M EUR.
In which sector is Braxia Scientific located?▼
Braxia Scientific operates in the Other sector.
When did Braxia Scientific complete a stock split?▼
Braxia Scientific has not had any recent stock splits.